These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 17032913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model.
    Lee JY, Choi BI, Son KR, Lee JM, Kim SJ, Park HS, Chang JM, Choi SH, Kim MA, Moon WK.
    Radiology; 2012 May; 263(2):391-400. PubMed ID: 22517957
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of lymph node metastases: comparison of gadofluorine M-enhanced MRI and diffusion-weighted MRI in a rabbit VX2 rectal cancer model.
    Kim SH, Lee JM, Moon SK, Chung YE, Paik JH, Choi SH, Kim MU, Han JK, Choi BI.
    J Magn Reson Imaging; 2012 May; 35(5):1179-86. PubMed ID: 22247081
    [Abstract] [Full Text] [Related]

  • 4. Early MR lymphography with gadofluorine M in rabbits.
    Misselwitz B, Platzek J, Weinmann HJ.
    Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine.
    Kim SJ, Moon WK, Choi SH, Chang JM, Cho N.
    Eur J Radiol; 2012 Aug; 81(8):1751-7. PubMed ID: 21477960
    [Abstract] [Full Text] [Related]

  • 7. [MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].
    Spuentrup E, Ruhl K, Weigl S, Misselwitz B, Wardeh D, Buhl A, Botnar RM, Katoh M, Wiethoff AJ, Günther RW.
    Rofo; 2010 Aug; 182(8):698-705. PubMed ID: 20419610
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
    Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM, Group.
    Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of lymph node metastases by contrast-enhanced MR imaging in a head and neck cancer model.
    Lee KC, Moon WK, Chung JW, Choi SH, Cho N, Cha JH, Lee EH, Kim SM, Kim HS, Han MH, Chang KH.
    Korean J Radiol; 2007 Sep; 8(1):9-14. PubMed ID: 17277558
    [Abstract] [Full Text] [Related]

  • 14. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
    Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ.
    Radiology; 2002 Jan; 222(1):239-44. PubMed ID: 11756732
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model.
    Frericks BB, Kühl AA, Loddenkemper C, Stroux A, Valdeig S, Hotz B, Misselwitz B, Hoffmann JC, Wacker FK.
    Invest Radiol; 2011 Aug; 46(8):478-85. PubMed ID: 21512398
    [Abstract] [Full Text] [Related]

  • 20. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
    Vandecaveye V, De Keyzer F, Vander Poorten V, Dirix P, Verbeken E, Nuyts S, Hermans R.
    Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.